Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

BACKGROUND: Primary Human Papilloma Virus (HPV) testing is the currently recommended cervical cancer (CxCa) screening strategy by the Portuguese Society of Gynecology (SPG) clinical consensus. However, primary HPV testing has not yet been adopted by the Portuguese organized screening programs. This...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pista, A (author)
Outros Autores: Costa, C (author), Saldanha, C (author), Moutinho, JA (author), Moutinho, JM (author), Arrobas, F (author), Catalão, C (author), Kempers, J (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Infecções por Papillomavirus
Neoplasias do Colo do Útero
Análise Custo-Benefício
Papillomavirus
Uterine Cervical Neoplasms
Cost-Benefit Analysis
Texto completo:http://hdl.handle.net/10400.26/28139
País:Portugal
Oai:oai:comum.rcaap.pt:10400.26/28139

Texto Completo

http://hdl.handle.net/10400.26/28139

Registos relacionados